| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/2013 | US8609670 Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| 12/17/2013 | US8609669 Potassium channel modulators |
| 12/17/2013 | US8609668 Substituted triazolo[1,5-A]pyrimidines as antiviral agents |
| 12/17/2013 | US8609666 2-morpholino-pyrido[3,2-D]pyrimidines |
| 12/17/2013 | US8609665 Solvate and crystalline forms of carbamoyl-cyclohexane derivatives |
| 12/17/2013 | US8609664 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/17/2013 | US8609663 Compounds for modulating TLR2 |
| 12/17/2013 | US8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases |
| 12/17/2013 | US8609661 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor |
| 12/17/2013 | US8609659 Substituted 3,8-diazabicyclo[3.2.1]octane compounds |
| 12/17/2013 | US8609658 N,N-dialkylalkylenyl esters, compositions thereof, and methods for use thereof |
| 12/17/2013 | US8609657 Compounds |
| 12/17/2013 | US8609656 Heteroarylphenylurea derivative |
| 12/17/2013 | US8609655 Calcimimetic compound for use in the treatment of epithelial injury |
| 12/17/2013 | US8609654 Compounds for enzyme inhibition |
| 12/17/2013 | US8609653 Azaindole compounds and methods for treating HIV |
| 12/17/2013 | US8609652 Method of administering a methylene blue-curcumin analog for the treatment of alzheimer's disease |
| 12/17/2013 | US8609650 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 12/17/2013 | US8609649 Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases |
| 12/17/2013 | US8609648 Hepatitis C virus inhibitors |
| 12/17/2013 | US8609647 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof |
| 12/17/2013 | US8609646 Enhanced erythropoiesis and iron metabolism |
| 12/17/2013 | US8609645 Pharmaceutical formulation |
| 12/17/2013 | US8609644 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/17/2013 | US8609643 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs |
| 12/17/2013 | US8609642 Skin treatment compositions |
| 12/17/2013 | US8609641 (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist |
| 12/17/2013 | US8609640 Multikinase inhibitors for use in the treatment of cancer |
| 12/17/2013 | US8609639 Stat3 inhibitor having anti-cancer activity and methods |
| 12/17/2013 | US8609638 Enzyme inhibiting compounds and methods |
| 12/17/2013 | US8609637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1H)-one and derivatives thereof |
| 12/17/2013 | US8609636 Oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 12/17/2013 | US8609635 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 12/17/2013 | US8609634 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| 12/17/2013 | US8609633 Core 2 GlcNAc-T inhibitors |
| 12/17/2013 | US8609632 Low molecular weight heparin composition and uses thereof |
| 12/17/2013 | US8609631 Compositions and methods for treating cancer |
| 12/17/2013 | US8609630 Vitamin B12 compositions |
| 12/17/2013 | US8609629 Kits and methods for nutrition supplementation |
| 12/17/2013 | US8609628 Fused pentacyclic polyethers |
| 12/17/2013 | US8609627 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections |
| 12/17/2013 | US8609625 Method for enhancing immune response in the treatment of infectious and malignant diseases |
| 12/17/2013 | US8609623 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 12/17/2013 | US8609622 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 12/17/2013 | US8609616 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| 12/17/2013 | US8609165 Dietary supplement for optimizing glucose levels, increasing energy, and improving general health |
| 12/17/2013 | US8609154 Anti-inflammatory cyclooxygenase inhibitors |
| 12/17/2013 | US8609151 Treatment of erectile dysfunction and libido enhancement |
| 12/17/2013 | US8609150 Fungicidal composition and method for controlling plant diseases |
| 12/17/2013 | US8609144 Sustained release intraocular implants and methods for preventing retinal dysfunction |
| 12/17/2013 | US8609142 Drug loaded polymeric nanoparticles and methods of making and using same |
| 12/17/2013 | US8609141 Silver ion delivery platform |
| 12/17/2013 | US8609138 ω3 fatty acid compound preparation |
| 12/17/2013 | US8609137 Soft capsule of butylphthalide and a process for preparing the same |
| 12/17/2013 | US8609135 Anthracycline derivatives |
| 12/17/2013 | US8609123 Derivatized poly(ester amide) as a biobeneficial coating |
| 12/17/2013 | US8609117 Compositions comprising jasmonic acid derivatives and use of the derivatives |
| 12/17/2013 | US8609081 Cyclodextrin-based polymers for therapeutics delivery |
| 12/17/2013 | US8609080 Methods and compositions for controlled release of drugs |
| 12/17/2013 | US8609079 Longwearing, transfer resistant cosmetic compositions having a unique creamy texture and feel |
| 12/17/2013 | US8609075 Heparanase activity inhibitor |
| 12/17/2013 | US8607989 Filter composites for drug detoxification |
| 12/17/2013 | CA2785694C Coated solid montelukast preparation |
| 12/17/2013 | CA2774250C C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 12/17/2013 | CA2758473C Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia |
| 12/17/2013 | CA2757838C Synthetic endoxifen for treating mammalian diseases |
| 12/17/2013 | CA2754154C Method for the industrial purification of biologically active phycotoxins |
| 12/17/2013 | CA2749114C Heteroatom-containing cyclic compound |
| 12/17/2013 | CA2748520C Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 12/17/2013 | CA2742947C Antioxidant |
| 12/17/2013 | CA2735929C Hydroxamic acid derivatives useful as antibacterial agents |
| 12/17/2013 | CA2733533C Hedgehog pathway modulators |
| 12/17/2013 | CA2729495C Pyrimidine derivatives as kinase inhibitors |
| 12/17/2013 | CA2729343C Topical steroidal formulations |
| 12/17/2013 | CA2697051C Substituted-quinoxaline-type piperidine compounds and the uses thereof |
| 12/17/2013 | CA2696232C Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 12/17/2013 | CA2691961C Catecholamine derivatives and prodrugs thereof |
| 12/17/2013 | CA2668068C Combination therapy of substituted oxazolidinones |
| 12/17/2013 | CA2667416C Process for making crystalline anhydrous docetaxel |
| 12/17/2013 | CA2664219C Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 12/17/2013 | CA2659774C Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 12/17/2013 | CA2652499C Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 12/17/2013 | CA2651769C Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists |
| 12/17/2013 | CA2648503C Method for producing high-purity prasugrel or an acid addition salt thereof |
| 12/17/2013 | CA2637388C Pyrrolopyridazinone compound |
| 12/17/2013 | CA2636040C Metabolites of wortmannin analogs and methods of using the same |
| 12/17/2013 | CA2633481C Preventive or therapeutic agent for acute renal failure |
| 12/17/2013 | CA2626454C Difluorophenol derivatives and their use |
| 12/17/2013 | CA2624449C Use of neboglamine in the treatment of toxicodependency |
| 12/17/2013 | CA2620554C Treatment of autoimmune diseases |
| 12/17/2013 | CA2618550C Indole derivatives as crth2 receptor antagonists |
| 12/17/2013 | CA2617578C Methods and compositions for regenerating articular cartilage |
| 12/17/2013 | CA2617051C Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 12/17/2013 | CA2615751C N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 12/17/2013 | CA2613874C Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs |
| 12/17/2013 | CA2612333C Inhibition of osteolytic lesions by src kinase inhibitors |
| 12/17/2013 | CA2611893C Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5 |
| 12/17/2013 | CA2607803C Compositions and methods for inhibiting gastric acid secretion |
| 12/17/2013 | CA2597273C Proteasome inhibitors and methods of using the same |
| 12/17/2013 | CA2568993C S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |